Fluconazole-induced torsade de pointes

Annals of Pharmacotherapy

Volumn 35, Issue 4, 2001, Pages 432-434

  Tholakanahalli, Venkatakrishna N ^a   Potti, Anil ^a   Hanley, James F ^a   Merliss, Andrew D ^b  

^a UND School of Medicine & Health Sciences Southeast Campus   (United States)

^b MeritCare Medical Center   (United States)

Author keywords

Fluconazole; Torsade de pointes

Indexed keywords

FLUCONAZOLE;

ABSCESS; AGED; ARTICLE; CANDIDA GLABRATA; CASE REPORT; DRUG WITHDRAWAL; FEMALE; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE TACHYCARDIA; HUMAN; PRIORITY JOURNAL; QT INTERVAL; TORSADE DES POINTES;

AGED; ANTIFUNGAL AGENTS; CANDIDIASIS; DIVERTICULITIS; ELECTROCARDIOGRAPHY; FEMALE; FLUCONAZOLE; HUMANS; POSTOPERATIVE COMPLICATIONS; TORSADES DE POINTES;

EID: 0035091104     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.10210     Document Type: Article

References (13)

1. Drugs causing prolongation of QT interval and torsades de pointes
2. Long QT syndrome and torsade de pointes in a patient receiving fluconazole
3. Prolonged QT interval and torsades de pointes caused by the combination of fluconazole and amitriptyline
4. The QT interval and torsades de pointes
5. Torsades de pointes after treatment with terfenadine and ketoconazole
6. Torsades de pointes after terfenadine - Itraconazole interaction
7. Drug-induced torsade de pointes
8. Downregulation of delayed rectifier K(+) currents in dogs with chronic complete atrioventricular block and acquired torsade de pointes
9. A practical approach to torsade de pointes
10. A method for estimating the probability of adverse drug reactions
11. Cardiac actions of erythromycin: Influence of female sex
12. Female gender as a risk factor for drug-induced cardiac arrhythmias: Evaluation of clinical and experimental evidence
13. Pharmacokinetic - Pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition